Principal Financial Group
COGT icon

Principal Financial Group’s Cogent Biosciences COGT Stock Holding History

Principal Financial Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.84M Buy
125,158
+41,214
+49% +$1.44M ﹤0.01% 1674
2026
Q1 		$3.23M Sell
83,944
-27,862
-25% -$1.03M ﹤0.01% 1743
2025
Q4 		$3.97M Sell
111,806
-160,654
-59% -$4.52M ﹤0.01% 1692
2025
Q3 		$3.91M Buy
+272,460
New +$3.23M ﹤0.01% 1674
2024
Q3 		– Sell
-16,211
Closed -$137K – 2264
2024
Q2 		$137K Sell
16,211
-3,704
-19% -$28.1K ﹤0.01% 2190
2024
Q1 		$134K Sell
19,915
-228
-1% -$1.41K ﹤0.01% 2239
2023
Q4 		$118K Sell
20,143
-1,124
-5% -$8.61K ﹤0.01% 2246
2023
Q3 		$207K Buy
21,267
+2,803
+15% +$33.2K ﹤0.01% 2160
2023
Q2 		$219K Buy
18,464
+1,379
+8% +$15.8K ﹤0.01% 2159
2023
Q1 		$184K Buy
17,085
+2,505
+17% +$32K ﹤0.01% 2196
2022
Q4 		$169K Buy
+14,580
New +$181K ﹤0.01% 2225

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group's COGT Position: Q2 2026 in Review

Principal Financial Group increased its Cogent Biosciences (COGT) stake by 49% in Q2 2026, buying an estimated $1.44M and bringing the position to 125,158 shares worth $4.84M. The position accounts for ﹤0.01% of the portfolio, ranked #1674.

Principal Financial Group first reported a position in COGT in Q4 2022 and has held it in 11 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Principal Financial Group held 125,158 shares of Cogent Biosciences worth $4.84M as of Q2 2026.
  • Principal Financial Group bought 41,214 Cogent Biosciences shares in Q2 2026, an estimated $1.44M.
  • Cogent Biosciences made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #1674 holding.
  • Principal Financial Group first reported a position in Cogent Biosciences in Q4 2022 and has held it in 11 quarters since.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.